Skip to main content

Advertisement

Log in

Patterns in detection of recurrence among patients treated for breast cancer

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Purpose

The Danish follow-up program for breast cancer (BC) patients has recently been changed. Today most patients are offered open access to an outpatient clinic, whereas the scheduled visits are phased out. This strategy has been studied in regards to psychological and health-related quality of life outcomes, but not in regards to detection of recurrence and survival. The aim of this study was to quantify the recurrences detected at scheduled outpatient visits in Denmark before the implementation of revised follow-up guidelines.

Methods

We conducted a cross-sectional study among 310 patients with recurrent BC. Information was retrieved on tumor characteristics, type of visit when recurrence was detected, recurrence localization, symptoms reported, and duration of symptoms from the Danish Breast Cancer Group database and medical records.

Results

The recurrences were locoregional (26%), locoregional and distant (15%), or distant (59%). Among patients still in outpatient follow-up (n = 199), recurrence was detected at a patient-requested extra outpatient visit (15%), by the general practitioner or other specialist (47%), at a scheduled outpatient visit (21%), or on a scheduled mammogram (11%). Among patients with recurrences detected at scheduled outpatient visits, the majority (88%) reported symptoms related to the recurrence. Most frequent symptoms were pain (37%), dyspnoea (15%), and fatigue (12%).

Conclusions

One-fifth of BC recurrences among patients attending outpatient follow-up were detected at scheduled outpatient visits. Very few of these were asymptomatic. Whether there will be a delay in detection of the symptomatic recurrences when the number of visits is reduced is unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Data are available as presented in this paper. According to the Danish legislation, we are not allowed to make patient data available to other parties. The study group welcomes collaboration with other researchers using our data. Study protocols can be planned in collaboration with us, and the study material can be analyzed accordingly at the Danish Cancer Society Research Center in Copenhagen, Denmark.

References

  1. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66:271–289

    Article  PubMed  Google Scholar 

  2. Holme O, Bretthauer M, Loberg M, Kalager M, Adami HO (2019) Revisiting surveillance schemes for cancer survivors. Ann Oncol 30:881–883

    Article  CAS  PubMed  Google Scholar 

  3. Davies NJ, Batehup L (2011) Towards a personalised approach to aftercare: a review of cancer follow-up in the UK. J Cancer Surviv Res Pract 5:142–151

    Article  Google Scholar 

  4. Santeufemia DA, Miolo G (2019) Cancer survivors: surveillance or not surveillance? Ann Oncol 30:1531

    Article  CAS  PubMed  Google Scholar 

  5. Høeg BL, Bidstrup PE, Karlsen RV, Friberg AS, Albieri V, Dalton SO, Saltbæk L, Andersen KK, Horsboel TA, Johansen C (2019) Follow-up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Database Syst Rev 11:CD012425

    Google Scholar 

  6. Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E (2019) Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 30:1194–1220

    Article  CAS  PubMed  Google Scholar 

  7. The Danish Breast Cancer Group, DBCG (2015) Guideline for follow-up. (In Danish. Retningslinjer. Kap. 9 Opfølgning). Available at https://www.dbcg.dk/PDF/Kap_9_Opfoelgning_og_kontrol-11.12.2015.pdf. Accessed 3 Apr 2020

  8. Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V (1994) Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up. JAMA 271:1593–1597

    Article  CAS  PubMed  Google Scholar 

  9. The GIVIO Investigators (1994) Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 271:1587–1592

    Article  Google Scholar 

  10. Kokko R, Hakama M, Holli K (2003) Role of chest X-ray in diagnosis of the first breast cancer relapse: a randomized trial. Breast Cancer Res Treat 81:33–39

    Article  CAS  PubMed  Google Scholar 

  11. Moschetti I, Cinquini M, Lambertini M, Levaggi A, Liberati A (2016) Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 5:001768

    Google Scholar 

  12. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA et al (2016) American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 34:611–635

    Article  CAS  PubMed  Google Scholar 

  13. The Danish Health Authority (2018) National breast cancer pathway (In Danish. Pakkeforløb for brystkræft. For fagfolk). Available at https://www.sst.dk/da/udgivelser/2018/pakkeforloeb-for-brystkraeft. Accessed 3 Apr 2020

  14. Brown L, Payne S, Royle G (2002) Patient initiated follow up of breast cancer. Psycho-Oncol 11:346–355

    Article  Google Scholar 

  15. Kirshbaum MN, Dent J, Stephenson J, Topping AE, Allinson V, McCoy M, Brayford S (2017) Open access follow-up care for early breast cancer: a randomised controlled quality of life analysis. Eur J Cancer Care (Engl). https://doi.org/10.1111/ecc.12577

    Article  Google Scholar 

  16. Koinberg IL, Fridlund B, Engholm GB, Holmberg L (2004) Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study. Eur J Oncol Nurs 8:109–117

    Article  Google Scholar 

  17. Sheppard C, Higgins B, Wise M, Yiangou C, Dubois D, Kilburn S (2009) Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs 13:2–8

    Article  CAS  Google Scholar 

  18. Kontos M, Roy P, Rizos D, Hamed H (2011) An evidence based strategy for follow up after breast conserving treatment for breast cancer. J Surg Oncol 104:223–227

    Article  Google Scholar 

  19. Lu W, de Bock GH, Schaapveld M, Baas PC, Wiggers T, Jansen L (2011) The value of routine physical examination in the follow up of women with a history of early breast cancer. Eur J Cancer 47:676–682

    Article  PubMed  Google Scholar 

  20. Geurts SM, de Vegt F, Siesling S, Flobbe K, Aben KK, van der Heiden-van der Loo M, Verbeek AL, van Dijck JA, Tjan-Heijnen VC (2012) Pattern of follow-up care and early relapse detection in breast cancer patients. Breast Cancer Res Treat 136(859):868

    Google Scholar 

  21. Koedijk MS, van der Sangen MJ, Poortmans PM, van Mierlo-Jansen P, van den Broek WT, Storck BH, Voogd AC (2013) Effectiveness of routine follow-up in the detection of contralateral breast cancer in young women with early breast cancer. Eur J Surg Oncol 39:1186–1191

    Article  CAS  PubMed  Google Scholar 

  22. Montgomery DA, Krupa K, Cooke TG (2007) Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer 97:1632–1641

    Article  CAS  PubMed  Google Scholar 

  23. Montgomery DA, Krupa K, Jack WJ, Kerr GR, Kunkler IH, Thomas J, Dixon JM (2007) Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience. Br J Cancer 96:1802–1807

    Article  CAS  PubMed  Google Scholar 

  24. te Boekhorst DS, Peer NG, van der Sluis RF, Wobbes T, Ruers TJ (2001) Periodic follow-up after breast cancer and the effect on survival. Eur J Surg 167:490–496

    Article  Google Scholar 

  25. Hiramanek N (2004) Breast cancer recurrence: follow up after treatment for primary breast cancer. Postgrad Med J 80:172–176

    Article  CAS  PubMed  Google Scholar 

  26. Christiansen P, Ejlertsen B, Jensen MB, Mouridsen H (2016) Danish Breast Cancer Cooperative Group. Clin Epidemiol 8:445–449

    Article  PubMed  Google Scholar 

  27. Stata Statistical Software: Release 14. College Station, TX, USA. Available at https://www.stata.com/stata14/

  28. Hvidberg L, Pedersen AF, Wulff CN, Vedsted P (2014) Cancer awareness and socio-economic position: results from a population-based study in Denmark. BMC Cancer 14:581. https://doi.org/10.1186/1471-2407-14-581

    Article  PubMed  Google Scholar 

  29. Balasubramaniam K, Elnegaard S, Rasmussen S, Haastrup PF, Christensen RD, Sondergaard J, Jarbol DE (2018) Lifestyle, socioeconomic status and healthcare seeking among women with gynaecological cancer alarm symptoms: a combined questionnaire-based and register-based population study. BMJ Open 8:e021815. https://doi.org/10.1136/bmjopen-2018-021815

    Article  PubMed  Google Scholar 

  30. Garcia Fernandez A, Chabrera C, Garcia Font M, Fraile M, Gonzalez S, Barco I, Gonzalez C, Cirera L, Veloso E, Lain JM et al (2013) Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012. Tumour Biol 34:2349–2355

    Article  CAS  PubMed  Google Scholar 

  31. Bodilsen A, Offersen BV, Christiansen P, Overgaard J (2016) Pattern of relapse after breast conserving therapy, a study of 1519 early breast cancer patients treated in the Central Region of Denmark 2000–2009. Acta Oncol 55:964–969

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank all participants in the study. We are also grateful for the financial support we received to conduct the study from the Danish Cancer Society, Region Zealand, and Rigshospitalet.

Funding

This study was supported by the Danish Cancer Society (Grant No. DCS 12714019), Region Zealand, and Rigshospitalet, the two latter without grant numbers. These institutions funded the work, but they were not involved in designing the study; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lena Saltbæk.

Ethics declarations

Conflicts of interest

All authors declare that they have no conflict of interest.

Ethical approval

The study was approved by the Danish Data Protection Agency (J.nr. 2015-41-4345). It was presented to the Committee on Health Research Ethics, and they confirmed that the study did not need their approval. The study was performed in accordance with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Saltbæk, L., Horsboel, T.A., Offersen, B.V. et al. Patterns in detection of recurrence among patients treated for breast cancer. Breast Cancer Res Treat 184, 365–373 (2020). https://doi.org/10.1007/s10549-020-05847-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-020-05847-4

Keywords

Navigation